Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
pembrolizumab
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biogen
biotech
cancer
cancer immunotherapy
clinical trials
deals
diagnostics
drug prices
gene therapy
generic drugs
What
drug
3
×
bio
new
roundup
acquisitions
albert
approval
approved
biggest
biogen’s
biopharmaceutical
bourla
cancer
ceo
companies
company
convo
crispr
deeper
dna
earlier
failures
fda
fingerprint
future
genetic
going
imports
littered
maker
maps
matter
measured
medicine
nash
nd
news
oks
patients
pfizer
Language
unknown
Current search:
merck
×
pembrolizumab
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues